Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in mice.

about

Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in mice.

Item

http://www.wikidata.org/entity/Q50021960

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Sphingosine kinase 2 supports ...... ymphoblastic leukemia in mice.

@en

Sphingosine kinase 2 supports ...... ymphoblastic leukemia in mice.

@nl

type

Item

label

Sphingosine kinase 2 supports ...... ymphoblastic leukemia in mice.

@en

Sphingosine kinase 2 supports ...... ymphoblastic leukemia in mice.

@nl

prefLabel

Sphingosine kinase 2 supports ...... ymphoblastic leukemia in mice.

@en

Sphingosine kinase 2 supports ...... ymphoblastic leukemia in mice.

@nl

P1476

Sphingosine kinase 2 supports ...... ymphoblastic leukemia in mice.

@en

P2093

Daochen Tong

http://www.w3.org/2001/XMLSchema#string

Ken F Bradstock

http://www.w3.org/2001/XMLSchema#string

Vicki Xie

http://www.w3.org/2001/XMLSchema#string

P2860

Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer.

Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent

Essential role for sphingosine kinases in neural and vascular development

RAG-1-deficient mice have no mature B and T lymphocytes

Transient expression of the Arf tumor suppressor during male germ cell and eye development in Arf-Cre reporter mice

Sphingosine kinase 1: A novel independent prognosis biomarker in hepatocellular carcinoma.

The expression of sphingosine kinase-1 in head and neck carcinoma

Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy.

Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2

Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate.

P2888

s40364-018-0120-4

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40364-018-0120-4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Craig T Wallington-Beddoe

Linda Bendall

P577

2018-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100823648

http://www.w3.org/2001/XMLSchema#string

P698

29441205

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

5800079

http://www.w3.org/2001/XMLSchema#string